Georg Karpel-Massler

BH-3 mimetics combined with CUSP9 – Multi-targeting meets repurposing

Christian Rainer Wirtz, Michal Hlavac, Marc-Eric Halatsch, 2018 .

BH3-mimetics and BET-inhibitors elicit enhanced lethality in malignant glioma

Georg Karpel-Massler, Chang Shu, M. Halatsch, 2017, Oncotarget.

Impaired Cerebral Vasomotor Activity in Spontaneous Intracerebral Hemorrhage

André Rupp, Georg Karpel-Massler, O. Sakowitz, 2009, Stroke.

EXTH-79. INITIAL EXPERIENCES WITH COMPASSIONATE-USE CUSP9v3/v4 FOR RECURRENT GLIOBLASTOMA

Georg Karpel-Massler, Bernd Schmitz, Marc-Eric Halatsch, 2017 .

A conceptually new treatment approach for relapsed glioblastoma: Coordinated undermining of survival paths with nine repurposed drugs (CUSP9) by the International Initiative for Accelerated Improvement of Glioblastoma Care

Alireza Khoshnevisan, Thomas Efferth, Daniele Focosi, 2013, Oncotarget.